Latest news
Creative Medical gets USPTO notice of allowance for exosome-based Type 1 diabetes immunotherapy patent application - BitgetBitget · Thu, 06 Aug 2026 16:00:55 GMTCreative Medical Receives U.S. Patent Allowance for Exosome-Based Type 1 Diabetes Immunotherapy - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 15:04:10 GMTCreative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 13:27:21 GMTExosome application gets U.S. allowance to target Type 1 diabetes autoimmunity - Stock TitanStock Titan · Thu, 06 Aug 2026 13:15:00 GMTVeru Announces Notice of Allowance for Key Methods of Use - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 12:30:00 GMTBio-Gene Raises $3.275 Million and Wins US Patent Allowance Extending Flavocide Protection to 2040 - kalkine.com.aukalkine.com.au · Fri, 31 Jul 2026 07:00:00 GMTFORESTA Secures NZD$35,000 Ara Ake Grant and US Patent Allowance for Pine Chemical Process - kalkine.com.aukalkine.com.au · Fri, 31 Jul 2026 04:14:41 GMTAdisyn Secures Second US Patent For Graphene-Coated Products - SMBtechSMBtech · Fri, 31 Jul 2026 00:55:11 GMT